
Loading, please wait...

Loading, please wait...

Researchers have identified new antiparasitic agents derived from 1,2,3-triazine, showing promising results against Trypanosoma cruzi and Leishmania mexicana. These neglected tropical diseases continue to pose significant public health challenges globally. Consequently, the discovery of novel chemical scaffolds is essential for improving therapeutic outcomes.
The study synthesized several derivatives, including 4-carboxylate-1,2,3-triazine 1-oxide and its analogs. Researchers evaluated these compounds for their in vitro and in vivo efficacy. Specifically, compound 2r exhibited a potency four times greater than benznidazole against T. cruzi epimastigotes. Furthermore, the 1,2,3-triazine (1i) and its dihydro analog (3i) reduced parasitemia by 40% in mouse models.
Regarding Leishmaniasis, compound 3r showed activity comparable to miltefosine. Additionally, compound 2i reduced parasitemia by up to 70% in vivo. These results suggest that 1,2,3-triazine derivatives could serve as a foundation for future drug development. The researchers also explored the inhibition of trypanothione reductase as a potential mode of action.
Moreover, these findings highlight the potential of N-oxide derivatives in affecting the antioxidant systems of protozoal parasites. This mechanism of action provides a distinct advantage over existing therapies. Therefore, the researchers believe these analogs warrant further clinical evaluation to address current treatment limitations.
Compound 2r demonstrated exceptional potency, being four times more effective than the standard treatment, benznidazole, in specific models.
Compound 3r showed similar efficacy to miltefosine, while compound 2i significantly reduced parasitemia in animal models, indicating high therapeutic potential.
Disclaimer: This content is for informational and educational purposes only. It is not intended to provide any medical advice or be used for diagnosing or treating any health problem or disease. Patients should always consult with a qualified healthcare professional for medical advice and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Navarrete-Carriola DV et al. Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis. Biomed Pharmacother. 2026 May 12. doi: undefined. PMID: 42119274.
2. World Health Organization. Leishmaniasis. Available at: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
3. Drugs for Neglected Diseases initiative (DNDi). Chagas Disease. Available at: https://dndi.org/diseases/chagas/

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study discovers 1,2,3-triazine derivatives that outperform benznidazole and miltefosine in treating Chagas disease and Leishmaniasis in preclinical models...
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today